Recent News

Atrium Hernia Mesh Lawsuits: Parties Prepare to Make Final Bellwether Trial Selections

The federal court overseeing hernia mesh lawsuits involving Atrium Medical’s C-Qur products continues to prepare for upcoming bellwether trials. According to a Case Management Order issued in the U.S. District Court, District of New Hampshire on December 17th, the parties … Continue reading

Elevated Levels of NDMA Lead to Appco Pharma Ranitidine Recall

Appco Pharma has become the latest drug maker to announce a ranitidine recall, after elevated levels of a potentially cancer-causing chemical were detected in the company’s generic version of Zantac. What’s Included in the Appco Ranitidine Recall? The recall affects … Continue reading

Texas Sex Trafficking Lawsuits Target Three National Hotel Chains

Three major hotel chains — Wyndham Hotels & Resorts, dba La Quinta Inn & Suites; Hilton Worldwide Holdings, dba Doubletree by Hilton; and Choice Hotels-Comfort Inn brands – have been named defendants in a trio of new sex trafficking lawsuits filed last month … Continue reading

Johnson & Johnson Reaches Mid-Trial Settlement in California Talcum Powder Lawsuit

Johnson & Johnson has agreed to settle a talcum powder lawsuit alleging asbestos-tainted Baby Powder was responsible for a woman’s cancer. Talcum Powder Settlement Reportedly Over $2 Million Jurors  in Alameda Superior Court had already heard two weeks of testimony, … Continue reading

FDA Approves Generic Uloric, Despite Link to Life-Threatening Heart Problems

The U.S. Food & Drug Administration (FDA) has approved another generic version of Uloric, despite evidence linking febuxostat to life-threatening heart problems. Novadoz Pharmaceuticals, the USA-based sales and marketing unit for India’s MSN Labs, announced it had begun shipping its … Continue reading

Renewed Push for Zantac Recall, After Second Lab Finds NDMA Develops During Storage

A second lab is pushing the U.S. Food & Drug Administration (FDA) to remove Zantac and all other ranitidine-containing heartburn drugs from the market, after new testing suggested a potentially cancer-causing contaminant can form while the medications are being stored. … Continue reading

Despite Xeljanz Blood Clot Risk, FDA Clears Extended Release Version for Ulcerative Colitis

The U.S. Food & Drug Administration (FDA) has approved Xeljanz XR to treat adults with moderate-to-severe active ulcerative colitis. According to a Pfizer, Inc. press release, the higher dose, extended release versions of Xeljanz are only indicated for ulcerative colitis … Continue reading

U.S. Congresswoman Calls on FDA to Order Zantac Recall

A prominent lawmaker is calling on the U.S. Food & Drug Administration (FDA) to order a recall of all Zantac and ranitidine heart burn drugs, amid concerns that the products could be contaminated with a cancer-causing chemical. FDA Failure to … Continue reading

Motel 6 in Colonie, New York Subject of New Sex Trafficking Lawsuit

A young woman from Saratoga County, New York is suing the Motel 6 hotel chain for allegedly enabling sex trafficking at various locations around the country, including a site in Colonie New York. Victim Allegedly Met Trafficker at Motel 6 … Continue reading

Allergan Breast Implant Lawsuits Centralized in New Jersey Federal Court

The U.S. Judicial Panel on Multidistrict Litigation has agreed to centralize all federally filed lawsuits involving Allergan, Inc’s recently recalled Biocell textured breast implants before a single judge in the U.S. District Court, District of New Jersey. “Allergan USA Inc. … Continue reading

Follow Us on Google+ on Facebook on LinkedIn on Twitter on YouTube on Pinterest